Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Meal Fat Content on Oral Testosterone Undecanoate PK
NCT02921386Phase 2Completed
- Sponsor
- Clarus Therapeutics
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of testosterone undecanoate in Hypogonadism (5 arms), sponsored by Clarus Therapeutics. Primary endpoints: Maximum Plasma Concentration, Time of Peak Concentration and 2 more. Started Oct 2016; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02921386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02921386.